|
2024
|
Invention
|
Use of inhibitors of bruton's tyrosine kinase (btk).
Methods are provided for treating a hematol... |
|
|
Invention
|
Crystalline forms of a bruton's tyrosine kinase inhibitor.
Described herein is the Bruton's tyro... |
|
2023
|
Invention
|
Inhibitors of bruton's tyrosine kinase.
Disclosed herein are compounds that form covalent bonds ... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase.
Described herein are irreversible kinase inhibitor compo... |
|
|
Invention
|
Methods of treating and preventing graft versus host disease.
Described herein are methods for t... |
|
|
Invention
|
Methods of treating and preventing alloantibody driven chronic graft versus host disease.
Descri... |
|
|
Invention
|
Methods of treating abc-dlbcl using inhibitors of brutons tyrosine kinase.
Disclosed herein are ... |
|
|
Invention
|
Synthesis of a bruton's tyrosine kinase inhibitor.
Described herein is the synthesis of Bruton's... |
|
|
Invention
|
Use of inhibitors of brutons tyrosine kinase (btk).
Disclosed herein are methods for treating a ... |
|
2021
|
Invention
|
Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor.
Described herein are pharma... |
|
|
Invention
|
Co-crystals of a bruton's tyrosine kinase inhibitor.
Disclosed are co-crystals of the Bruton's t... |
|
|
Invention
|
Crystalline forms of a brutons tyrosine kinase inhibitor.
Described herein is the Bruton's tyros... |
|
|
Invention
|
Solvated forms of a bruton's tyrosine kinase inhibitor.
Described herein are solvates of the Bru... |
|
2020
|
Invention
|
Use of inhibitors of brutons tyrosine kinase (btk).
Methods are provided for treating a hematolo... |
|
|
G/S
|
Medical services, namely, disease management programs; providing health information; telehealth s... |
|
|
G/S
|
medical services, namely, disease management programs; providing health information; telehealth s... |
|
|
Invention
|
Crystalline forms of a bruton's tyrosine kinase inhibitor. Described herein is the Bruton's tyros... |
|
|
Invention
|
Use of inhibitors of brutons tyrosine kinase (btk). Disclosed herein are methods for treating a c... |
|
|
Invention
|
Methods for the treatment of her2 amplified cancer.
Described herein are methods and composition... |
|
|
Invention
|
Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor. Described herein are pharmac... |
|
|
Invention
|
Crystalline forms of a brutons tyrosine kinase inhibitor. Described herein is the Bruton's tyrosi... |
|
|
Invention
|
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy.
Combinations of Bruton's ... |
|
|
Invention
|
Use of inhibitors of bruton's tyrosine kinase (btk). Disclosed herein are methods for treating a ... |
|
2019
|
Invention
|
Solvated forms of a bruton?s tyrosine kinase inhibitor.
Described herein are solvates of the Bru... |
|
|
Invention
|
Salts of 3-[(dimethylamino)methyl]-n-{2-[4-(hydroxycarbamoyl) phenoxy]ethyli-1-benzofuran-2-carbo... |
|
|
Invention
|
Methods of treating and preventing graft versus host disease. Described herein are methods for tr... |
|
|
Invention
|
Ibrutinib combination therapy.
Combinations of Bruton's tyrosine kinase (Btk) inhibitors, e.g., ... |
|
|
Invention
|
Inhibitors of brutons tyrosine kinase.
Disclosed herein are reversible and irreversible inhibito... |
|
|
Invention
|
Tec family kinase inhibitor adjuvant therapy.
Described herein are methods and compositions comp... |
|
|
Invention
|
Inhibitors of brutons tyrosine kinase.
Described herein are irreversible kinase inhibitor compou... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors.
Described herein are i... |
|
|
Invention
|
Bruton's tyrosine kinase inhibitor combinations and uses thereof.
Disclosed arc compositions, me... |
|
2014
|
G/S
|
Pharmaceuticals; pharmaceutical preparations for the treatment of cancer, immune mediated disease... |
|
2013
|
G/S
|
Pharmaceuticals for the treatment of cancer |
|
2012
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
2009
|
G/S
|
Pharmaceutical preparations for the treatment of cancer, immune mediated diseases, inflammatory d... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer,
immune mediated diseases, inflammatory ... |
|
|
G/S
|
pharmaceutical preparations for the treatment of cancer, immune mediated diseases, inflammatory d... |
|
2000
|
G/S
|
Pharmaceuticals for diagnosis and treatment of cancer. |
|
1993
|
G/S
|
pharmaceuticals used as [ magnetic resonance imaging contrast agents and ] therapeutics for cance... |
